We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

231 hedge funds and large institutions have $2.61B invested in Axsome Therapeutics in 2023 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 90 increasing their positions, 54 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 16

75% more call options, than puts

Call options by funds: $106M | Put options by funds: $60.5M

67% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 54

33% more capital invested

Capital invested by funds: $1.97B → $2.61B (+$647M)

17% more funds holding

Funds holding: 197 → 231 (+34)

4.83% more ownership

Funds ownership: 73.31% → 78.14% (+4.8%)

11% less funds holding in top 10

Funds holding in top 10: 9 → 8 (-1)

Holders
231
Holders Change
+34
Holders Change %
+17.26%
% of All Funds
3.63%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.13%
New
50
Increased
90
Reduced
54
Closed
16
Calls
$106M
Puts
$60.5M
Net Calls
+$45.1M
Net Calls Change
+$22.7M

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$73.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$56.4M
3
RI
RTW Investments
New York
+$37.1M
4
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$34M
5
DTC
Deep Track Capital
Connecticut
+$28.3M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$51.8M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$44.7M
3
Holocene Advisors
Holocene Advisors
New York
-$32.6M
4
Millennium Management
Millennium Management
New York
-$22.4M
5
WP
Woodline Partners
California
-$9.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
IPW
226
Impact Partnership Wealth
Georgia
$1.08K +$1.11K +15 New
BIA
227
Bell Investment Advisors
California
$935 +$959 +13 New
NSIM
228
North Star Investment Management
Illinois
$934 – – –
GWSG
229
GPS Wealth Strategies Group
Colorado
$790 – – –
FGAM
230
Financial Gravity Asset Management
Texas
$151 +$738 +10 +16%
Holocene Advisors
231
Holocene Advisors
New York
– -$32.6M -529,144 Closed
ECM
232
ExodusPoint Capital Management
New York
– -$5.96M -96,684 Closed
TI
233
Trexquant Investment
Connecticut
– -$1.4M -22,732 Closed
SG Americas Securities
234
SG Americas Securities
New York
– -$818K -13,269 Closed
Verition Fund Management
235
Verition Fund Management
Connecticut
– -$575K -9,316 Closed
BCM
236
Bayesian Capital Management
New York
– -$452K -7,324 Closed
FC
237
Financial Consulate
Maryland
– -$322K -5,220 Closed
ACM
238
Aquatic Capital Management
Illinois
– -$278K -4,500 Closed
SEC
239
Seven Eight Capital
New York
– -$236K -3,819 Closed
BAM
240
Blueshift Asset Management
New Jersey
– -$232K -3,763 Closed
BHCM
241
Boulder Hill Capital Management
New York
– -$204K -3,300 Closed
CG
242
Cutler Group
California
– -$159K -2,156 Closed
ASN
243
Advisory Services Network
Georgia
– -$82.2K -1,333 Closed
DFCM
244
Dark Forest Capital Management
Puerto Rico
– -$50.9K -825 Closed
TAM
245
Tucker Asset Management
Colorado
– -$12.5K -203 Closed
TWA
246
TCI Wealth Advisors
Arizona
– -$6.66K -108 Closed
C
247
Covestor
United Kingdom
– -$148 -2 -50%
6 7 8 9
10

AXSM Hedge Fund Activity: Q2 2023 in Review

231 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q2 2023, worth a combined $2.61B — up 33% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new AXSM positions and 16 closed out — a net gain of 34 holders — while 90 added to existing stakes and 54 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $73.8M. The largest seller was Point72 Asset Management, cutting an estimated $51.8M.

  • 231 institutional investors held Axsome Therapeutics (AXSM) as of Q2 2023, up from 197 in Q1 2023.
  • Funds reported $2.61B of Axsome Therapeutics stock for Q2 2023, up 33% quarter-over-quarter.
  • 50 funds opened new Axsome Therapeutics positions in Q2 2023 and 16 closed out, a net change of +34 holders.
  • The largest Axsome Therapeutics buyer in Q2 2023 was RA Capital Management, an estimated $73.8M added.
  • The largest Axsome Therapeutics seller in Q2 2023 was Point72 Asset Management, an estimated $51.8M sold.

Based on aggregated 13F filings for Q2 2023.